Journals / Medical Network Klinik Bilimler ve Doktor / 2005 / Cilt: 11 - Sayı: 4

Lincomycin induced Stevens Johnson syndrome: Case report

Linkomisine bağlı Stevens Johnson sendromu: Olgu sunumu

Pages
360–363
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Lincomycin induced SJS is a rare conditions in the literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Erythema multiforme is an inflammatory skin eruption with erythematous, edematous or bullous lesions.
📊
Key Findings & Data:Mortality is about %5.
💡
Conclusion & Impact:Lincomycin induced SJS is a rare conditions in the literature.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Linkomisin · Anti-bakteriyel ajanlar · Stevens-Johnson sendromu

Abstract

Erythema multiforme is an inflammatory skin eruption with erythematous, edematous or bullous lesions. Stevens Johnson Syndrome (SJS) is the serious form of Erythema multiforme involving oral mucosae, pharynx, conjunctival surfaces and anogenital area. Mortality is about %5. SJS may represent in antibiotics usage. Lincomycin is an antibiotic, which cause to SJS, as well. We presented a 40 years old female patient with Lincomycin induced SJS after Lincomycin usage for upper respiratory tract infection. The patient had wide spread maculopapular lesions, vesiculobullose eruptions in anogenital and oral mucosa. She had also symptoms and laboratory findings of intrahepatic cholestasis. Lincomycin induced SJS is a rare conditions in the literature.

Özet

Stevens Johnson sendromu (SJS); Eritema Multiforme olarak adlandırılan deri ve mukozaları tutan eritemli, ödemli veya büllöz lezyonların görüldüğü enflamatuvar deri döküntüsünün oral mukoza, farinks, anogenital bölge ve konjonktivada büllerle seyreden ağır bir formudur. Mortalite %5 düzeyindedir. Antibiyotik kullanımı sonucu görülebilir; Linkomisin de SJS'a yol açabilen antibiyotiklerdendir. Burada üst solunum yolu enfeksiyonu nedeniyle Linkomisin kullanımı sonrası, vücutta yaygın makülopapüler, anogenital bölge ve oral mukozada ise vezikülobüllöz döküntüleri olan, hematüri ve intrahepatik kolestaz bulguları saptanan "Linkomisine bağlı Stevens Johnson Sendromu" tanılı 40 yaşında bayan hasta sunulmuştur. Literatür tarandığında Linkomisine bağlı SJS'nun çok nadir rapor edildiği görülmüştür.

🔖

Cite This Article

KIRMAZ, C., ÜNAL, N. G., BAYRAK, P., KILIÇÇIOĞLU, B. (2005). Lincomycin induced Stevens Johnson syndrome: Case report. Medical Network Klinik Bilimler ve Doktor, Cilt: 11 - Sayı: 4, 360–363. https://ajindex.com/articles/278417

References (12)

  1. Inachi S, Mizutani H, Shimizu M. Epidermal apoptotic cell death in erythema multiforme and Stevens-Johnson Syndrome. Arch Dermatol 1997; 133:845-9
  2. Fritsch PO, Ruiz-Maldonado R. Stevens-Johnson syndrome and Toxic epidermal necrolysis. In: İM Freedberg, AZ Eisen, L Wolff, HF Austen, LA Goldsmith, SI Katz, TB Fitzpatrick editors. Dermatology in General Medicine. New York: McGraw-Hill, 1999:644-54
  3. Sane SP, Bhatt AD. Stevens-Johnson syndrome and toxic epidermal necrolysis-challenges of recognition and management. J Assoc Physicians India 2000; 48:999-1003
  4. Garcia-Doval I, LeCleach L, Bocquet H, Otero XL, Roujeau Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death? Arch Dermatol 2000; 136:323-7
  5. Cunha BA. Antibiotic side effects. Med Clin North Am 2001; 49-85
  6. Roujeau JC, Kelly J, Naldi L, Berthold R, Stern R, Anderson t al. Medication use and the risk of Stevens-Johnson rome or toxic epidermal necrolysis. N Engl J Med 1995; 1600-7
  7. Watkinson G. Sulphasalazine: a review of 40 years experience. Drugs. 1986; 32 (Suppl 1):1-11
  8. Linkozamidler. In: Güneş B., editör. Türkiye Tıbbi İlaç Rehberi Farmalist. Ankara: Farmatıp Yayıncılık 1998:108
  9. Chan J, Lai FM. A case of Stevens-Johnson syndrome, cholestatic hepatitis and hemoiytic anemia associated with the use of mefenamic acid. Drug Safety 1991; 6:230-4
  10. Senturk T, Aydintug AO, Duzgun N, Tokgoz G. Seizures and hepatotoxicity following sulphasalazine administration. Rheumatol Int 1997; 17:75-7
  11. Gremse DA, Bancroft J, Moyer MS. Sulfasalazine hyper-sensitivity with hepatotoxicity, thrombocytopenia, and erythroid hypoplasia. J Pediatr Gastroenterol Nutr 1989; 9:261-3
  12. Humes HD. Diagnostic and Therapeutic Modalities in Rheumatologic and Allerjic Diseases. In: Kelley's Textbook of Internal Medicine. Philadelphia: Lippincott Williams & Wilkins Company 2000:1451.